- Report
- May 2025
- 191 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- February 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
From €4447EUR$4,900USD£3,749GBP
- Report
- May 2025
- 184 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 184 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 195 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 184 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- January 2025
- 100 Pages
Global
From €5400EUR$5,950USD£4,552GBP
- Report
- November 2024
- 100 Pages
Global
From €5400EUR$5,950USD£4,552GBP
- Report
- October 2024
- 100 Pages
Global
From €5400EUR$5,950USD£4,552GBP
- Report
- May 2025
- 193 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 194 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 197 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 199 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 175 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- April 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- April 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- April 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- April 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- April 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics.
The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more